Before visiting, please review our current visitor policies and COVID-19 information.
Testing The Addition Of Radiation Therapy To The Usual Immune Therapy Treatment (Atezolizumab) For Patients With Extensive Stage Small Cell Lung Cancer
To determine if can we extend the time without your extensive small cell lung cancer growing or spreading by adding radiation therapy to the usual treatment for this type of cancer.
DiagnosisPatients have extensive stage small cell lung cancer.
MRI brain with contrast or CT brain with contrast
CT chest, abdomen and pelvis or whole body PET/CT scan after the fourth cycle of chemotherapy
Patients must have had measurable disease
Patients must have three or fewer observable liver metastases
No evidence of progressive disease
Patients must sign an approved informed consent and authorization permitting release of personal health information.
This study has two study groups.
- Group 1: Patients in this group will continue to get the usual immune therapy drug, atezolizumab every 3 weeks.
- Group 2: Patients in this group will get radiation therapy plus the usual immune therapy drug (atezolizumab) used to treat this type of cancer.
For more information, visit ClinicalTrials.gov